908 Devices Inc. (MASS) stock
MASSNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 11/3028% above fair value
$9.74−0.05 (-0.51%)
Close on Nov 13, 2026Market cap $402.59MP/E –Yield –
908 Devices total assets
Total assets on the balance sheet at the end of each period.
908 Devices's total assets was $199.36M at Sep 30, 2026. For fiscal 2025 it was $190.07M, up 19.2% from the year before. The highest annual figure on record is $260.91M in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $190.07M | +19.2% |
| FY2024 | Dec 31, 2024 | $159.48M | -21.4% |
| FY2023 | Dec 31, 2023 | $202.98M | -16.3% |
| FY2022 | Dec 31, 2022 | $242.59M | -7.0% |
| FY2021 | Dec 31, 2021 | $260.91M | +45.9% |
| FY2020 | Dec 31, 2020 | $178.83M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $199.36M | +4.4% |
| Q2 FY2026 | Jun 30, 2026 | $197.54M | +3.0% |
| Q1 FY2026 | Mar 31, 2026 | $186.70M | -4.8% |
| Q4 FY2025 | Dec 31, 2025 | $190.07M | +19.2% |
| Q3 FY2025 | Sep 30, 2025 | $190.87M | +7.1% |
| Q2 FY2025 | Jun 30, 2025 | $191.70M | -8.2% |
| Q1 FY2025 | Mar 31, 2025 | $196.03M | +3.3% |
| Q4 FY2024 | Dec 31, 2024 | $159.48M | -21.4% |
| Q3 FY2024 | Sep 30, 2024 | $178.28M | -14.5% |
| Q2 FY2024 | Jun 30, 2024 | $208.77M | -1.0% |
| Q1 FY2024 | Mar 31, 2024 | $189.79M | -13.1% |
| Q4 FY2023 | Dec 31, 2023 | $202.98M | -16.3% |
| Q3 FY2023 | Sep 30, 2023 | $208.48M | -16.4% |
| Q2 FY2023 | Jun 30, 2023 | $210.83M | -14.6% |
| Q1 FY2023 | Mar 31, 2023 | $218.41M | -13.1% |
| Q4 FY2022 | Dec 31, 2022 | $242.59M | -7.0% |
| Q3 FY2022 | Sep 30, 2022 | $249.28M | +49.9% |
| Q2 FY2022 | Jun 30, 2022 | $247.00M | +48.4% |
| Q1 FY2022 | Mar 31, 2022 | $251.23M | +46.3% |
| Q4 FY2021 | Dec 31, 2021 | $260.91M | +45.9% |
| Q3 FY2021 | Sep 30, 2021 | $166.30M | – |
| Q2 FY2021 | Jun 30, 2021 | $166.48M | – |
| Q1 FY2021 | Mar 31, 2021 | $171.75M | – |
| Q4 FY2020 | Dec 31, 2020 | $178.83M | – |
See a number that looks wrong?